CLYMB CLINICAL
Live / Registered — Registered (as of 13 Oct 2026)
What this means for you
Registered since 13 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 97627417
- Registration number
- 8503499
- Mark type
- Word mark
- Filed
- 11 Oct 2022
- Published for opposition
- 19 Aug 2025
- Registered
- 13 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 13 Oct 2032 (grace period to 13 Apr 2033)
- Attorney of record
- John Mirkin
Goods and services
- Class 042 — Scientific and technological services: Consulting services for others in the field of tables, figures and listings (TFL) design, data planning, and implementation project management of clinical trials for the pharmaceutical and biotechnical industries
Owner
- Clymb Clinical LLC, Bedford, MA, US
- Clymb Clinical LLC, Bedford, MA, US
- Clymb Clinical LLC, Bedford, MA, US
Prosecution history
- 13 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 May 2026 — NON-FINAL ACTION E-MAILED
- 19 May 2026 — SU - NON-FINAL ACTION - WRITTEN
- 13 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Oct 2025 — USE AMENDMENT FILED
- 10 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 14 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT